A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.
Spatial transcriptomics in diabetic macular ischaemia
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government
Composition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype
Redefining macular disease diagnosis to improve access to emerging therapies
Investigating mitochondrial dysfunction in macular degeneration – towards new treatments and biomarkers
Evaluating the potential of hyperspectral imaging for detecting and monitoring geographic atrophy Accurate monitoring of
Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia